<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01021176</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 27016</org_study_id>
    <nct_id>NCT01021176</nct_id>
  </id_info>
  <brief_title>Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell</brief_title>
  <official_title>A Single Dose Pilot Study to Evaluate the Safety and Dose-Response of Smell to Intranasal Diltiazem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Compellis Pharmaceuticals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the blood pressure medication, diltiazem,
      will temporarily decrease the sense of smell when given in a nasal spray which will then
      reduce food intake.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      You will fast on your first visit. Complete questionnaire about taste and smell to insure you
      don't have a cold or anything that would interfere with sense of smell. Your nose will be
      checked. Blood pressure taken, and administer to you a spray with diltiazem 2, 4, 8 mg or a
      placebo. Your sense of smell will be tested at different time points.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of blood pressure medication, diltiazem, will temporarily decrease the sense of smell when given in a nasal spray.</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Food Intake</condition>
  <arm_group>
    <arm_group_label>0mg 0 spray</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No Diltiazem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2mg 2 Spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 2mg/2 spray Diltiazem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4mg 4 Spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 4mg/4 spray Diltiazem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8mg 8 spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 8mg/8 spray Diltiazem</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo spray</intervention_name>
    <description>0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray yet no drug will be administered</description>
    <arm_group_label>0mg 0 spray</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diltiazem</intervention_name>
    <description>0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray Three Dilutions would be 5.5, 6.0 and 6.3 and the fourth at the filp of a coin randomly diluted.</description>
    <arm_group_label>2mg 2 Spray</arm_group_label>
    <arm_group_label>4mg 4 Spray</arm_group_label>
    <arm_group_label>8mg 8 spray</arm_group_label>
    <other_name>5.5, 6.0, 6.3 and/or one more randomly</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) between 25 and 40 kg

          -  Blood pressure in within normal range

        Exclusion Criteria:

          -  Used tobacco products in the past month

          -  Used a calcium channel blocker medication in the last month

          -  used nasal sprays in the last month

          -  have an abnormal sense of smell or abnormalities of the lining in your nose

          -  female and have irregular menstrual periods

          -  female and are nursing a baby or pregnant

          -  female and have had a partial hysterectomy (still have ovaries)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank L. Greenway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2009</study_first_posted>
  <last_update_submitted>December 17, 2015</last_update_submitted>
  <last_update_submitted_qc>December 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Frank Greenway</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Food Intake</keyword>
  <keyword>Hunger</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Nose</keyword>
  <keyword>smell</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diltiazem</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

